new_adrs_0322_0835|GLMD|0|total_current_assets|cash_on_hand|inventories_net|net_ppe|goodwill_and_intangible|liabilities|total_current_liabilities|total_long_term_liab|total_deposits|book_value_of_equity|retained_earnings|treasury_stock|ev_revenues|ev_earnings|ev_free_cash_flow|ev_assets|ps_ratio|pe_ratio|price_to_book_value|peg_ratio|debt_equity_ratio|dividend_yield|shareholder_yield_ttm|percent_of_shares_outstanding|receivables|payables|capital_stock|return_on_invested_capital|quality_ratio_fractile|momentum_fractile|market_beta_12_month|sustainable_growth_rate|institutional_investor_ownership_percentage|average_shares_outs_diluted|total_employee_number|eps|shares_outstanding|repurchase_of_capital_stock|ordinary_shares_number|payout_ratio|quick_ratio|normalized_eps|stock_buyback|effective_tax_rate|return_on_equity|net_income_ttm|revenues_ttm|dividend_per_share|revenues|gross_profit|sga_expense|pre_tax_income|net_income|interest_income|price|total_return_price|enterprise_value|average_volume_30|one_year_return|price_next_month|price_second_month
new_adrs_0322_0835|GLMD|1|Galmed Pharmaceuticals Ltd Total Current Assets (Quarterly) (USD)|Galmed Pharmaceuticals Ltd Cash and Short Term Investments (Quarterly) (USD)|Galmed Pharmaceuticals Ltd Inventories (Quarterly) (USD)|Galmed Pharmaceuticals Ltd Net PP&E (Quarterly) (USD)|Galmed Pharmaceuticals Ltd Goodwill and Intangibles (Quarterly) (USD)|Galmed Pharmaceuticals Ltd Total Liabilities (Quarterly) (USD)|Galmed Pharmaceuticals Ltd Total Current Liabilities (Quarterly) (USD)|Galmed Pharmaceuticals Ltd Total Long Term Liabilities (Quarterly) (USD)|Galmed Pharmaceuticals Ltd Total Deposits (Quarterly) (USD)|Galmed Pharmaceuticals Ltd Book Value (Quarterly) (USD)|Galmed Pharmaceuticals Ltd Retained Earnings (Quarterly) (USD)|Galmed Pharmaceuticals Ltd Treasury Stock (Quarterly) (USD)|Galmed Pharmaceuticals Ltd EV to Revenues|Galmed Pharmaceuticals Ltd EV to Earnings|Galmed Pharmaceuticals Ltd EV to Free Cash Flow|Galmed Pharmaceuticals Ltd EV to Assets (Quarterly)|Galmed Pharmaceuticals Ltd PS Ratio|Galmed Pharmaceuticals Ltd PE Ratio|Galmed Pharmaceuticals Ltd Price to Book Value|Galmed Pharmaceuticals Ltd PEG Ratio|Galmed Pharmaceuticals Ltd Debt to Equity Ratio|Galmed Pharmaceuticals Ltd Dividend Yield|Galmed Pharmaceuticals Ltd Shareholder Yield (TTM)|Galmed Pharmaceuticals Ltd Percent of Shares Outstanding Short|Galmed Pharmaceuticals Ltd Total Receivables (Quarterly) (USD)|Galmed Pharmaceuticals Ltd Total Payables (Quarterly) (USD)|Galmed Pharmaceuticals Ltd Total Capital Stock (Quarterly) (USD)|Galmed Pharmaceuticals Ltd Return on Invested Capital|Galmed Pharmaceuticals Ltd Quality Ratio Score|Galmed Pharmaceuticals Ltd Momentum Score|Galmed Pharmaceuticals Ltd Beta (1Y)|Galmed Pharmaceuticals Ltd Sustainable Growth Rate (TTM)|Galmed Pharmaceuticals Ltd Institutional Investor Ownership Percentage|Galmed Pharmaceuticals Ltd Average Diluted Shares Outstanding (Quarterly)|Galmed Pharmaceuticals Ltd Total Employees (Annual)|Galmed Pharmaceuticals Ltd EPS Diluted (Quarterly) (USD)|Galmed Pharmaceuticals Ltd Shares Outstanding|Galmed Pharmaceuticals Ltd Repurchase of Capital Stock (Quarterly) (USD)|Galmed Pharmaceuticals Ltd Ordinary Shares Number (Quarterly)|Galmed Pharmaceuticals Ltd Payout Ratio|Galmed Pharmaceuticals Ltd Quick Ratio (Quarterly)|Galmed Pharmaceuticals Ltd Normalized Diluted EPS (Quarterly) (USD)|Galmed Pharmaceuticals Ltd Stock Buybacks (Quarterly) (USD)|Galmed Pharmaceuticals Ltd Effective Tax Rate (TTM)|Galmed Pharmaceuticals Ltd Return on Equity|Galmed Pharmaceuticals Ltd Net Income (TTM) (USD)|Galmed Pharmaceuticals Ltd Revenue (TTM) (USD)|Galmed Pharmaceuticals Ltd Dividend Per Share (Quarterly) (USD)|Galmed Pharmaceuticals Ltd Revenue (Quarterly) (USD)|Galmed Pharmaceuticals Ltd Gross Profit (Quarterly) (USD)|Galmed Pharmaceuticals Ltd SG&A Expense (Quarterly) (USD)|Galmed Pharmaceuticals Ltd Pre-Tax Income (Quarterly) (USD)|Galmed Pharmaceuticals Ltd Net Income (Quarterly) (USD)|Galmed Pharmaceuticals Ltd Net Interest Income (Quarterly) (USD)|Galmed Pharmaceuticals Ltd Price (USD)|Galmed Pharmaceuticals Ltd Total Return Price (USD)|Galmed Pharmaceuticals Ltd Enterprise Value (USD)|Galmed Pharmaceuticals Ltd 30-Day Average Daily Volume|Galmed Pharmaceuticals Ltd 1 Year Price Returns (Daily)||
new_adrs_0322_0835|GLMD|2|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|percent_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|percent_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_beta|percent_USD_metric|percent_USD_metric|mil_figure_USD_metric|figure_whole_USD_metric|figure_money_USD_per_share_metric|mil_figure_USD_metric|mil_figure_money_USD_metric|mil_figure_USD_metric|percent_USD_metric|figure_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_money_USD_price|mil_figure_money_USD_metric|figure_USD_metric|percent_USD_metric||
new_adrs_0322_0835|GLMD|4|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|quarterly|daily|quarterly|monthly|quarterly|monthly|quarterly|quarterly|daily|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|monthly|quarterly|yearly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|monthly|monthly|monthly||
new_adrs_0322_0835|GLMD|5|91.2903225806|91.2903225806||91.2903225806||91.2903225806|91.2903225806|91.2903225806||91.2903225806|91.2903225806||7|91.3529411765|6.98568019093|91.3|7||7.00963855422||91.25|1.44972758791|91.4|15.2251308901|91.2903225806|91.2903225806|91.2903225806|91.4||31.2|30.4337349398|91.4|30.2857142857|91.3235294118|365.285714286|91.3235294118|55.16||91.2903225806|91.4|91.25|91.3235294118|91.3235294118||91.4|91.2903225806|91.4||91.25||91.3235294118|91.3235294118|91.3235294118|91.3235294118|7.01918465228|7.01918465228|7.01918465228|7.00242718447|7.01917808219||
new_adrs_0322_0835|GLMD|6|31|31||31||31|31|31||31|31||246|17|419|20|246||415||8|2019|5|191|31|31|31|5||80|83|5|14|34|7|34|50||31|5|8|34|34||5|31|5||8||34|34|34|34|417|417|417|412|365||
new_adrs_0322_0835|GLMD|7|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|daily|quarterly|daily|daily|daily|daily|quarterly|daily|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|monthly|quarterly|yearly|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|market_daily|market_daily|daily|market_daily|market_daily||
new_adrs_0322_0835|GLMD|201303||||||||||||||||||||||||||||||||||5.0695||-0.1197||||||-0.1197|||||||||0.139|-0.607|-0.607|-0.004|||||||
new_adrs_0322_0835|GLMD|201306||||||||||||||||||||||||||||||||||5.0695||-0.188||||||-0.188|||||||||0.108|-0.953|-0.953|-0.005|||||||
new_adrs_0322_0835|GLMD|201309||||||||||||||||||||||||||||||||||5.0695||-0.1306||||||-0.1306|||||||||0.086|-0.66|-0.662|0.005|||||||
new_adrs_0322_0835|GLMD|201312|0.153|0.137||0.013||2.117|1.689|0.428||-1.951|-27.642||||||||||||||0.011|1.355|0.01|||||||10.6748|10|-1.4298|||10.6748|||-1.4298|-0.12|||-17.485|||||7.022|-15.264|-15.263|-2.908|||||||
new_adrs_0322_0835|GLMD|201403|39.863|39.769||0.018||1.928|1.498|0.43||37.953|-29.803||||-48.4602||||3.3547|||||0.1115|0.094|1.498|0.032|||||||7.98||-0.27|11.1005||11.1005|||-0.27|-41.856|||-19.039|||||0.633|-2.161|-2.161|-0.026|10.925|10.925|116.4852|157008.5||9.25|6.81
new_adrs_0322_0835|GLMD|201406|37.46|37.399||0.024||1.136|0.694|0.442||36.348|-31.56||||-15.2322||||2.7756|||||0.2165|0.061|0.694|0.032|||||||11.1005||-0.14|11.1005||11.1005|||-0.14||||-19.843|||||0.518|-1.757|-1.757|0.006|9.8|9.8|69.0159|26687.5333||7.92|6.83
new_adrs_0322_0835|GLMD|201409|35.409|35.342||0.775||2.933|2.565|0.368||33.251|-34.766||||-7.939||||2.871|||||0.5263|0.067|2.565|0.032|||||||11.1005||-0.29|11.1005||11.1005|||-0.29||||-22.387|||||0.399|-3.206|-3.206|-0.016|8.79|8.79|60.1744|228963.0667||6.67|5.9
new_adrs_0322_0835|GLMD|201412|32.151|31.986||0.774||1.518|1.118|0.4||31.407|-36.745||||-4.1866||||2.0164|||||0.1907|0.064|0.875|0.032|||||||11.0699|13|-0.17|11.1005||11.1005|||-0.17||||-9.103|||||0.928|-1.978|-1.979|0.076|5.71|5.71|28.0419|35036.6667||6.52|9.49
new_adrs_0322_0835|GLMD|201503|30.275|29.887||0.773||1.561|1.356|0.205||29.487|-39.208||||-7.4345||||3.5462|||||0.3711|0.388|1.356|0.032|||4|1.2228|||11.1005||-0.22|11.1005||11.1005|||-0.22||||-9.405|||||1.073|-2.463|-2.463|0.041|10.03|10.03|79.352|81033.7333|-8.1922|9.195|9.35
new_adrs_0322_0835|GLMD|201506|28.195|27.81||0.915||1.695|1.501|0.194||27.415|-41.562||||-8.7767||||4.0734|||||0.6506|0.385|1.501|0.032|||10|1.1455|||11.1005||-0.21|11.1005||11.1005|||-0.21||||-10.002|||||0.967|-2.354|-2.354|0.175|10.06|10.06|83.861|41073.3333|3.2854|10.04|7.35
new_adrs_0322_0835|GLMD|201509|25.671|25.325||0.902||1.513|1.326|0.187||25.06|-44.162||||-5.698||||3.0004|||||0.7667|0.346|1.326|0.032|||9|2.5785|||11.1005||-0.23|11.1005||11.1005|||-0.23||||-9.396|||||0.637|-2.6|-2.6|-0.103|7.41|7.41|54.4447|25128.7667|-17.1141|9.47|8.99
new_adrs_0322_0835|GLMD|201512|23.38|23.001||0.883||2.718|2.541|0.177||21.545|-47.367||||-6.1817||||3.4196|||||0.6872|0.109|2.259|0.032|||10|3.7425|||11.1005|15|-0.29|11.1005||11.1005|||-0.29||||-10.622|||||0.569|-3.205|-3.205|0.14|7.72|7.72|60.3709|14110.5|24.1158|7.07|4.86
new_adrs_0322_0835|GLMD|201603|20.222|19.966||0.859||3.201|3.024|0.177||17.88|-51.351||||-3.3148||||2.3958|||||0.8661|0.256|3.024|0.032|||2|2.9107|||11.1005||-0.36|11.1005||11.1005|||-0.36||||-12.143|||||0.719|-3.984|-3.984|0.119|4.65|4.65|28.6163|33623.8333|-53.6391|6.21|4.19
new_adrs_0322_0835|GLMD|201606|17.161|16.682||0.84||3.575|3.353|0.222||14.426|-55.662||||-3.2157||||2.8186|||||0.5824|0.479|3.353|0.032|||2|2.6245|||11.1009||-0.39|11.1028||11.1028|||-0.39|-0.011|||-14.1|||||0.861|-4.31|-4.311|-0.089|4.54|4.54|30.4303|21299.8667|-56.555|4.15|3.81
new_adrs_0322_0835|GLMD|201609|18.673|18.307||0.791||3.934|2.86|1.074||15.53|-59.494||||-3.8689|1.8308|||4.0021|||||0.4725|0.366|1.815|0.034|||1|2.7089|||11.15||-0.34|12.1492||12.1492||6.529|-0.34|-4.468|||-15.332|||0.193||0.656|-3.727|-3.832|0.078|5.2|5.2|41.0526|153188.8667|-40.5034|3.75|3.62
new_adrs_0322_0835|GLMD|201612|15.732|15.448||0.718||5.375|4.579|0.796||11.075|-64.32||||-2.2545|1.6532|||2.8567|||||0.9562|0.03|3.485|0.034|||1|1.8857|||12.1945|16|-0.4|12.1492||12.1492||3.3802|-0.4||||-16.953|||0.274||0.842|-4.826|-4.826|0.207|3.6516|3.6516|26.057|35528.4333|-57.1408|4.08|5.199
new_adrs_0322_0835|GLMD|201703|11.989|11.653||0.665||4.356|3.819|0.537||8.298|-67.482||||-3.4594|3.7816|||5.1888|||||0.9261|0.336|2.734|0.034|||3|2.855|||12.165||-0.26|12.1689||12.1689||3.1393|-0.26||||-16.131|||0.268||0.789|-3.162|-3.162|0.102|4.73|4.73|42.0177|39689.2333|-1.2526|5.01|4.86
new_adrs_0322_0835|GLMD|201706|9.421|9.155||0.606||3.785|3.635|0.15||6.242|-70.174||66.2848|-4.5904|-4.7611|6.6437|73.5554||8.8282||||-5.8967|0.583|0.266|2.55|0.034|-141.0815||7|3.8082|-130.5717||12.1751||-0.22|12.2192||12.2192||2.5917|-0.22|||-130.5717|-14.512|1.005||0.27||0.624|-2.692|-2.692|0.009|6.02|6.02|61.6038|36857.1|41.6471|8.21|8.03
new_adrs_0322_0835|GLMD|201709|9.129|8.958||0.548||3.145|2.995|0.15||6.532|-72.975||105.929|-7.9687|-8.4045|11.1012|108.4174||18.603||||-2.2812|0.457|0.171|2.184|0.036|-141.3784||10|5.3622|-141.3784||12.3642||-0.23|12.7335||12.7335||3.0481|-0.23|-2.655||-141.3784|-13.481|1.085||0.273||0.697|-2.801|-2.801|-0.046|9.18|9.18|106.9647|30436.9667|76.5385|8.25|7.96
new_adrs_0322_0835|GLMD|201712|19.152|18.997||0.491||3.848|3.848|||15.795|-76.619||107.4538|-9.1947|-8.7216|5.757|103.0933||17.9387||||-11.3694|0.1333|0.055|3.31|0.04|-128.2696||10|1.5542|-128.2696||13.1258|17|-0.27|14.4352||14.4352||4.9511|-0.27|-12.362||-128.2696|-12.299|1.085||0.274||1.689|-3.644|-3.644|0.088|8.54|8.54|108.2176|86506.2|133.8701|9.98|5.12
new_adrs_0322_0835|GLMD|201803|15.867|15.502||0.433||2.698|2.698|||13.602|-79.125||60.0085|-5.5921|-4.8254|3.9944|66.9078||4.8929||||-18.6289|0.1576|0.365|2.428|0.04|-115.348||7|3.4537|-115.348||14.4676||-0.17|14.4724||14.4724||5.881|-0.17|||-115.348|-11.643|1.085||0.268||0.883|-2.506|-2.506|0.053|5.34|5.34|58.2856|118057.9|12.8964|6.15|5.89
new_adrs_0322_0835|GLMD|201806|94.473|94.105||0.374||3.804|3.804|||91.043|-81.81||175.5809|-13.2999|-16.3328|1.6317|155.5576||15.1454||||-37.8446|2.4156|0.368|3.804|0.058|-43.6741||7|2.8655|-43.6741||15.7117||-0.17|20.9128||20.9128||24.8352|-0.17|-79.164||-43.6741|-11.636|1.085||0.27||1.105|-2.685|-2.685|0.09|12.95|12.95|190.5053|1053012.0667|117.608|14.24|13.31
new_adrs_0322_0835|GLMD|201809|92.603|92.317||0.284||2.139|2.139|||90.748|-82.769||176.942|-19.6972|-18.6481|2.0769|175.4741||3.1423||||-32.0722|1.4856|0.286|2.139|0.058|-22.4922||9|2.5834|-22.4922||20.9534||-0.05|21.0038||21.0038||43.2927|-0.05|0.046||-22.4922|-9.794|2.312||1.5||0.987|-0.884|-0.959|0.296|13.68|13.68|191.9821|150569.2|43.8251|10.16|8.57
new_adrs_0322_0835|GLMD|201812|90.406|90.188||0.194||2.706|2.706|||87.894|-86.475||26.0253|-5.4494|-6.4616|0.5746|50.4452||1.6803|||||0.551|0.051|2.706|0.058|||8|3.4735|||21.047|21|-0.18|21.0189||21.0189|||-0.18|-0.031|||-9.856|||||1.465|-3.706|-3.706|0.478|7.26|7.26|60.1706|143337.4333|-15.5172|7.64|8.24
new_adrs_0322_0835|GLMD|201903|86.979|86.562||0.857||2.908|2.409|0.499||84.928|-89.967||35.5995|-8.7739|-9.0317|0.9251|63.7661||1.9625|||||3.454|0.417|2.409|0.058|||10|2.5964|||21.0843||-0.17|21.1131||21.1131|||-0.17||||-10.842|||||0.771|-3.492|-3.492|0.548|8.17|8.17|82.306|153370.4333|59.5703|7.81|6.39
new_adrs_0322_0835|GLMD|201906|84.328|83.623||0.783||3.724|3.282|0.442||81.387|-94.136||22.3741|-7.3125|-5.4612|0.771|55.8085||1.6283|||||2.8465|0.705|3.282|0.058|||8|2.7492|||21.1201||-0.2|21.1213||21.1213|||-0.2||||-12.326|||||1.207|-4.169|-4.169|0.532|6.55|6.55|51.7288|55870.4|-50.687|6.14|5.15
new_adrs_0322_0835|GLMD|201909|80.628|79.73||0.724||3.929|3.54|0.389||77.423|-98.65||8.8689|-2.169|-1.8297|0.2287|44.8886||1.2794|||||1.7618|0.898|3.54|0.058|||2|2.6335|||21.1234||-0.21|21.1241||21.1241|||-0.21||||-15.881|||||0.953|-4.514|-4.514|0.493|4.93|4.93|20.505|77940.2|-62.614|3.75|4.59
new_adrs_0322_0835|GLMD|201912|76.43|75.491||0.709||7.286|6.934|0.352||69.853|-106.936||20.1967|-4.7677|-3.1236|0.5027|52.7857||1.7492|||||2.1567|0.226|6.934|0.058|||2|3.2314|||21.1293|21|-0.39|21.1394||21.1394|||-0.39||||-20.461|||||1.265|-8.286|-8.286|0.347|5.78|5.78|46.6947|150212.2|-20.2721|5.81|5.54
new_adrs_0322_0835|GLMD|202003|69.792|68.889||0.647||6.335|6.033|0.302||64.104|-112.999||1.8603|-0.4392|-0.1432|0.0463|31.6233||1.1417|||||1.7645|0.79|6.033|0.058|||3|2.0176|||21.1508||-0.29|21.1532||21.1532|||-0.29||||-23.032|||||0.912|-6.063|-6.063|0.399|3.46|3.46|4.3011|98338.4667|-57.4671|4.31|5.34
new_adrs_0322_0835|GLMD|202006|64.211|63.429||0.638||4.965|4.714|0.251||59.884|-118.525||16.299|-3.8476|-2.2253|0.4057|43.7047||1.6885|||||2.2004|0.669|4.714|0.058|||4|1.9864|||21.1532||-0.26|21.1532||21.1532|||-0.26||||-24.389|||||0.845|-5.526|-5.526|0.29|4.78|4.78|37.6833|92091.8667|-19.8473|4.61|4.94
new_adrs_0322_0835|GLMD|202009|59.34|58.585||0.613||6.297|6.05|0.247||53.656|-125.43||4.1619|-1.6996|-0.7382|0.1792|31.6356||1.2199|||||0.2216|0.642|6.05|0.058|||5|1.9599|||21.2687||-0.32|21.312||21.312|||-0.32|-0.707|||-26.78|||||1.054|-6.905|-6.905|0.685|3.46|3.46|9.6223|65430.5333|-26.1663|3.14|3.82
new_adrs_0322_0835|GLMD|202012|51.811|50.886||0.57||8.228|8.012|0.216||44.153|-135.707||4.8955|-1.5763|-0.4924|0.1662|30.0414||1.3028|||||0.1535|0.066|8.012|0.058|||4|1.931||40.7595|21.5496|24|-0.48|21.326||21.326|||-0.48||||-28.771|||||1.317|-10.277|-10.277|-0.213|3.28|3.28|11.3184|128798.7|-43.2574|3.755|4.06
new_adrs_0322_0835|GLMD|202103|59.702|58.805||0.675||7.42|7.137|0.283||52.957|-144.612||14.1191|-2.7806|-0.9381|0.2932|30.6507||1.8918|||||1.1492|0.784|7.137|0.07|||2|2.1598||32.2964|23.3741||-0.38|25.0839||25.0839|||-0.38|-17.368|||-31.613|||||1.752|-8.905|-8.905|0.227|3.33|3.33|32.6434|375719.9333|-4.3103|3.35|2.44
new_adrs_0322_0835|GLMD|202106|51.665|51.065||0.66||7.326|7.008|0.318||44.999|-153.008||8.6325|-2.572|-0.8284|0.2712|29.6567||1.4873|||||2.6013|0.487|7.008|0.07|||1|1.8436||34.5078|25.0839||-0.33|25.0839||25.0839|||-0.33||||-34.483|||||1.376|-8.396|-8.396|0.016|3.14|3.14|19.9584|350244.8667|-35.124|2.41|3.27
new_adrs_0322_0835|GLMD|202109|43.692|41.905||0.606||6.622|6.348|0.274||37.676|-160.722||10.3529|-2.867|-0.6716|0.3023|29.5108||1.6667|||||1.2691|1.674|6.348|0.07|||2|1.625||26.5767|25.0839||-0.31|25.0839||25.0839|||-0.31||||-35.292|||||1.304|-7.714|-7.714|0.131|2.99|2.99|23.9359|104119.4333|-15.5367|2.46|2.52
new_adrs_0322_0835|GLMD|202112|||||||||||||1.5125||-0.059||18.6111||1.2051|||||0.7748||||||2|-0.6346||24.9822||||||||||||||||||||||1.81|1.81|3.4969|124122.1667|-44.1358|1.52|1.52
new_adrs_0322_0835|GLMD|202203|||||||||||||-1.1999||0.0822||16.0405||1.0386||||||||||||||||||||||||||||||||||||1.56|1.56|-2.7741|66966.1|-54.386||